Scinovex
article Open AccessTop 1% cited

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.

The Journal of Experimental Medicine · 1991 · Vol. 174(4) · pp. 915–924
René de Waal MalefytJohn B.A.G. HaanenHergen SpitsMaria Grazia RoncaroloA te VeldeCarl G. FigdorKeith JohnsonRob KasteleinHans YsselJ E de Vries

Abstract

Interleukin 10 (IL-10) and viral IL-10 (v-IL-10) strongly reduced antigen-specific proliferation of human T cells and CD4+ T cell clones when monocytes were used as antigen-presenting cells. In contrast, IL-10 and v-IL-10 did not affect the proliferative responses to antigens presented by autologous Epstein-Barr virus-lymphoblastoid cell line (EBV-LCL). Inhibition of antigen-specific T cell responses was associated with downregulation of constitutive, as well as interferon gamma- or IL-4-induced, class II MHC expression on monocytes by IL-10 and v-IL-10, resulting in the reduction in antigen-presenting capacity of these cells. In contrast, IL-10 and v-IL-10 had no effect on class II major histocompatibility complex (MHC) expression on EBV-LCL. The reduced antigen-presenting capacity of monocytes correlated with a decreased capacity to mobilize intracellular Ca2+ in the responder T cell clones. The diminished antigen-presenting capacities of monocytes were not due to inhibitory effects of IL-10 and v-IL-10 on antigen processing, since the proliferative T cell responses to antigenic peptides, which did not require processing, were equally well inhibited. Furthermore, the inhibitory effects of IL-10 and v-IL-10 on antigen-specific proliferative T cell responses could not be neutralized by exogenous IL-2 or IL-4. Although IL-10 and v-IL-10 suppressed IL-1 alpha, IL-1 beta, tumor necrosis factor alpha (TNF-alpha), and IL-6 production by monocytes, it was excluded that these cytokines played a role in antigen-specific T cell proliferation, since normal antigen-specific responses were observed in the presence of neutralizing anti-IL-1, -IL-6, and -TNF-alpha mAbs. Furthermore, addition of saturating concentrations of IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha to the cultures had no effect on the reduced proliferative T cell responses in the presence of IL-10, or v-IL-10. Collectively, our data indicate that IL-10 and v-IL-10 can completely prevent antigen-specific T cell proliferation by inhibition of the antigen-presenting capacity of monocytes through downregulation of class II MHC antigens on monocytes.

Immune Cell Function and InteractionT-cell and B-cell ImmunologyImmunotherapy and Immune ResponsesAntigenBiologyMajor histocompatibility complexT cellAntigen-presenting cellAntigen presentationImmunologyMolecular biologyImmune system

MeSH terms

Antibodies, MonoclonalCalciumCell Line, TransformedCells, CulturedCloning, MolecularDNA ReplicationHerpesvirus 4, HumanFluorescent Antibody TechniqueGenes, MHC Class IIHLA-DQ AntigensHLA-DR AntigensHumansLymphocyte ActivationMonocytesRecombinant Proteins
Citations
1,945
FWCI
21.87
field-weighted impact
References
32
Percentile
100%
vs. same field & year
Citations per year
Cited by
Cytokines in Inflammatory Bowel Disease
World Journal of Surgery · 1998 · 477 citations
The Biology of Chemokines and their Receptors
Annual Review of Immunology · 2000 · 2,401 citations
Interleukin-10 and the Interleukin-10 Receptor
Annual Review of Immunology · 2001 · 6,655 citations
Sir Isaac Newton, sepsis, SIRS, and CARS
Critical Care Medicine · 1996 · 989 citations
Effect of interleukin‐10 on dendritic cell maturation and function
European Journal of Immunology · 1997 · 569 citations
The paradoxical role of IL-10 in immunity and cancer
Cancer Letters · 2015 · 460 citations
References
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.